CBT
IONS icon

Central Bank & Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Central Bank & Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28
Closed -$1K – 377
2023
Q1 		$1K Buy
+28
New +$1.05K ﹤0.01% 380

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Central Bank & Trust's IONS Position: Q2 2023 in Review

Central Bank & Trust sold out of Ionis Pharmaceuticals (IONS) in Q2 2023, closing a stake of 28 shares — an estimated $1K sold.

Central Bank & Trust first reported a position in IONS in Q1 2023 and held it in 1 quarter. The position peaked at $1K in Q1 2023. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

  • Central Bank & Trust reported no remaining Ionis Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Central Bank & Trust sold 28 Ionis Pharmaceuticals shares in Q2 2023, an estimated $1K.
  • Central Bank & Trust first reported a position in Ionis Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Central Bank & Trust's Ionis Pharmaceuticals position peaked at $1K in Q1 2023.
  • 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on Central Bank & Trust's 13F filing for Q2 2023, filed 13 Jul 2023.